Robert W Yeh

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. doi request reprint Sources of hospital variation in short-term readmission rates after percutaneous coronary intervention
    Robert W Yeh
    Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Circ Cardiovasc Interv 5:227-36. 2012
  2. doi request reprint Predicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary intervention
    Robert W Yeh
    MSc, Cardiology Division, GRB 800, Massachusetts General Hospital, Boston, MA 02144
    Circulation 124:1557-64. 2011
  3. pmc Accounting for the mortality benefit of drug-eluting stents in percutaneous coronary intervention: a comparison of methods in a retrospective cohort study
    Robert W Yeh
    Cardiology Division, GRB800, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    BMC Med 9:78. 2011
  4. doi request reprint Do postmarketing surveillance studies represent real-world populations? A comparison of patient characteristics and outcomes after carotid artery stenting
    Robert W Yeh
    Cardiology Division, GRB 800, Massachusetts General Hospital, Boston, MA 02144, USA
    Circulation 123:1384-90. 2011
  5. doi request reprint Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography
    Taishi Yonetsu
    Division of Cardiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Am J Cardiol 110:933-9. 2012
  6. doi request reprint Efficacy and safety of argatroban in patients with heparin induced thrombocytopenia undergoing endovascular intervention for peripheral arterial disease
    Suzanne J Baron
    Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    Catheter Cardiovasc Interv 72:116-20. 2008
  7. doi request reprint What is the optimal anticoagulation level with argatroban during percutaneous coronary intervention?
    Ignacio Cruz-Gonzalez
    Cardiology Division, Massachusetts General Hospital, Harvard Medical School Boston, Massachusetts, USA
    Blood Coagul Fibrinolysis 19:401-4. 2008
  8. ncbi request reprint Analysis of cardiac dimensions, mass and function in heart transplant recipients using 64-slice multi-detector computed tomography
    Maros Ferencik
    Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
    J Heart Lung Transplant 26:478-84. 2007
  9. doi request reprint Pre-procedural Risk Quantification for Carotid Stenting Using the CAS Score: A Report From the NCDR CARE Registry
    Beau M Hawkins
    Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
    J Am Coll Cardiol 60:1617-22. 2012
  10. doi request reprint Comparison of nonculprit coronary plaque characteristics between patients with and without diabetes: a 3-vessel optical coherence tomography study
    Koji Kato
    Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    JACC Cardiovasc Interv 5:1150-8. 2012

Collaborators

Detail Information

Publications25

  1. doi request reprint Sources of hospital variation in short-term readmission rates after percutaneous coronary intervention
    Robert W Yeh
    Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Circ Cardiovasc Interv 5:227-36. 2012
    ..Little is known about variation in the performance of hospitals on this measure, and whether high hospital rates of readmission after PCI are due to modifiable deficiencies in quality of care has not been assessed...
  2. doi request reprint Predicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary intervention
    Robert W Yeh
    MSc, Cardiology Division, GRB 800, Massachusetts General Hospital, Boston, MA 02144
    Circulation 124:1557-64. 2011
    ..To assist physicians in targeting DES use in patients at the highest risk for target vessel revascularization (TVR), we developed and validated a model to predict TVR...
  3. pmc Accounting for the mortality benefit of drug-eluting stents in percutaneous coronary intervention: a comparison of methods in a retrospective cohort study
    Robert W Yeh
    Cardiology Division, GRB800, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    BMC Med 9:78. 2011
    ..In order to explore reasons for this discrepancy, we compared outcomes after percutaneous coronary intervention (PCI) with DES or BMS by multiple statistical methods...
  4. doi request reprint Do postmarketing surveillance studies represent real-world populations? A comparison of patient characteristics and outcomes after carotid artery stenting
    Robert W Yeh
    Cardiology Division, GRB 800, Massachusetts General Hospital, Boston, MA 02144, USA
    Circulation 123:1384-90. 2011
    ..Whether PMS studies are representative of carotid artery stenting in routine clinical practice has not been established...
  5. doi request reprint Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography
    Taishi Yonetsu
    Division of Cardiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Am J Cardiol 110:933-9. 2012
    ..In conclusion, lipid-rich neoatherosclerosis develops inside stents earlier in DESs than in BMSs. After 48 months, most restenotic stents will have developed lipid-laden neointima in both groups...
  6. doi request reprint Efficacy and safety of argatroban in patients with heparin induced thrombocytopenia undergoing endovascular intervention for peripheral arterial disease
    Suzanne J Baron
    Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
    Catheter Cardiovasc Interv 72:116-20. 2008
    ..This study aimed to evaluate the efficacy and safety of argatroban during percutaneous interventions for peripheral arterial disease (PAD)...
  7. doi request reprint What is the optimal anticoagulation level with argatroban during percutaneous coronary intervention?
    Ignacio Cruz-Gonzalez
    Cardiology Division, Massachusetts General Hospital, Harvard Medical School Boston, Massachusetts, USA
    Blood Coagul Fibrinolysis 19:401-4. 2008
    ..006). These results suggest that in patients undergoing percutaneous coronary intervention, argatroban provides adequate anticoagulation with a low bleeding rate, when activated clotting time is maintained below 450 s...
  8. ncbi request reprint Analysis of cardiac dimensions, mass and function in heart transplant recipients using 64-slice multi-detector computed tomography
    Maros Ferencik
    Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
    J Heart Lung Transplant 26:478-84. 2007
    ..The aim of this study was to compare 64-slice MDCT analysis of cardiac structure and function to 2-dimensional echocardiography in heart transplant recipients...
  9. doi request reprint Pre-procedural Risk Quantification for Carotid Stenting Using the CAS Score: A Report From the NCDR CARE Registry
    Beau M Hawkins
    Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
    J Am Coll Cardiol 60:1617-22. 2012
    ..We developed and internally validated a risk score to predict in-hospital stroke or death after carotid artery stenting (CAS)...
  10. doi request reprint Comparison of nonculprit coronary plaque characteristics between patients with and without diabetes: a 3-vessel optical coherence tomography study
    Koji Kato
    Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    JACC Cardiovasc Interv 5:1150-8. 2012
    ..The aim of the present study was to compare the characteristics of nonculprit coronary plaques between diabetes mellitus (DM) and non-DM patients using 3-vessel optical coherence tomography (OCT) imaging...
  11. doi request reprint A prediction model to identify patients at high risk for 30-day readmission after percutaneous coronary intervention
    Jason H Wasfy
    Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Circ Cardiovasc Qual Outcomes 6:429-35. 2013
    ..We aimed to develop and validate prediction models to assist clinicians and hospitals in identifying patients at highest risk for 30-day readmission after PCI...
  12. doi request reprint Anticoagulation with the direct thrombin inhibitor argatroban in patients presenting with acute coronary syndromes
    Robert W Yeh
    Division of Cardiology, Department of Medicine, University of California, San Francisco, San Francisco, California, USA
    Catheter Cardiovasc Interv 74:359-64. 2009
    ..This study examined the efficacy and safety of the direct thrombin inhibitor argatroban in patients presenting with acute coronary syndromes undergoing cardiac catheterization...
  13. doi request reprint Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice
    Amit P Amin
    Cardiovascular Division, Department of Medicine, Barnes Jewish Hospital, Washington University School of Medicine, St Louis, Missouri, USA
    Arch Intern Med 172:1145-52. 2012
    ..Our objective was to assess whether DES are preferentially used in patients with higher predicted TVR risk and to estimate if lower use of DES in low-TVR-risk patients would be more cost-effective than the existing DES use pattern...
  14. doi request reprint Risk prediction for adverse events after carotid artery stenting in higher surgical risk patients
    Neil J Wimmer
    Brigham and Women s Hospital, and Harvard Medical School, 1620 Tremont Street, Boston, MA 02120, USA
    Stroke 43:3218-24. 2012
    ..The aim of this study was to predict individual patient risk after carotid artery stenting in patients at higher risk for carotid endarterectomy...
  15. doi request reprint Safety and efficacy of the argatroban therapy during the early post-cardiac surgery period
    Joo Heung Yoon
    Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Bigelow 800, 55 Fruit Street, Boston, MA, 02114, USA
    J Thromb Thrombolysis 30:276-80. 2010
    ..In cardiac surgery patients with clinical suspicion of HIT, early postoperative use of argatroban seems well-tolerated and associated with a low risk of thrombotic events...
  16. doi request reprint Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study
    Koji Kato
    Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    Circ Cardiovasc Imaging 5:433-40. 2012
    ..The aim of this study was to compare the plaque characteristics of nonculprit lesions between ACS and non-ACS patients using optical coherence tomography (OCT) imaging...
  17. ncbi request reprint Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes
    Robert W Yeh
    Department of Medicine, University of California, San Francisco, San Francisco, California, USA
    Am J Cardiol 100:1734-8. 2007
    ..In conclusion, thrombocytopenia is a significant correlate of adverse events in patients presenting with non-ST-elevation ACS treated with either enoxaparin or UFH...
  18. doi request reprint Population trends in the incidence and outcomes of acute myocardial infarction
    Robert W Yeh
    Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, USA
    N Engl J Med 362:2155-65. 2010
    ..Few studies have characterized recent population trends in the incidence and outcomes of myocardial infarction...
  19. pmc Risk-treatment paradox in the selection of transradial access for percutaneous coronary intervention
    Neil J Wimmer
    Division of Cardiovascular Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    J Am Heart Assoc 2:e000174. 2013
    ..We sought to develop a prediction model for access site complications in patients undergoing PCI with femoral arteriotomy, and assess whether transradial access was selectively used in patients at high risk for complications...
  20. doi request reprint Rethinking the epidemiology of acute myocardial infarction: challenges and opportunities
    Robert W Yeh
    Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
    Arch Intern Med 170:759-64. 2010
    ....
  21. pmc Geographic disparities in the incidence and outcomes of hospitalized myocardial infarction: does a rising tide lift all boats?
    Robert W Yeh
    Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA
    Circ Cardiovasc Qual Outcomes 5:197-204. 2012
    ..However, no studies have examined regional differences in recent trends in MI incidence, and few have examined whether known regional disparities in MI care have narrowed over time...
  22. doi request reprint Another view of personalized medicine: optimizing stent selection on the basis of predicted benefit in percutaneous coronary intervention
    Neil J Wimmer
    Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02155, USA
    Trends Cardiovasc Med 22:23-8. 2012
    ....
  23. doi request reprint Management strategy in 249 consecutive patients with obstructive hypertrophic cardiomyopathy referred to a dedicated program
    Richard D Rothman
    Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston, USA
    Am J Cardiol 110:1169-74. 2012
    ..7-year follow-up, obviating SRT in these patients. Clinicians in programs offering SRT should optimize conservative therapy before recommending SRT...
  24. ncbi request reprint Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndrome
    Ignacio Cruz-Gonzalez
    Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Gray Bigelow 800, 55 Fruit Street, Boston, MA 02114, USA
    J Thromb Thrombolysis 25:214-8. 2008
    ....
  25. ncbi request reprint Comparison of sixty-four-slice multidetector computed tomographic coronary angiography to coronary angiography with intravascular ultrasound for the detection of transplant vasculopathy
    Shawn A Gregory
    Cardiology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Am J Cardiol 98:877-84. 2006
    ..Further, MDCT measurements of lumen diameters correlated well with quantitative coronary angiography...